Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Air India chief resigns 10 months after devastating Ahmedabad crash and amid mounting financial troubles- Over 1,800 killed since junta seized power in Burkina Faso, rights group says
- Ifo: Job cuts in Germany slowing but not enough for a turnaround
- Russia’s New KVS Drone May Be Designed To Restore Reach In The FPV War
- Select Your Cherished Fish
- 'Pluribus' release date: Everything you need to know about the new series from 'Better Call Saul's' co-creator
- Lower-cost space missions like NASA's ESCAPADE are starting to deliver exciting science – but at a price in risk and trade‑offs
- A definitive Bike Standoff: Decision in favor of Your Number one Ride
- US FDA grants market authorization to six on! PLUS nicotine pouch products
